SGH using IPO base resistance as support!* Great accelerating earnings
* Breaking out of its IPO base
* High 3-month relative strength in the Tech sector
* Using the broken resistance of the IPO base as support
* Formed a cup and handle pattern
* Holding up really well even in a correction
* Has been consolidating right above broken resistance for the past 4 weeks.
* Maximum probable ROI is ~41%
* Depth of the base is at ~70%
* Has been forming the base since 2018 so ~70% move up isn't unlikely
Trade Idea:
* Given the nature of the current market and if you don't mind a little volatility, now would be a great time to enter as it's constructing a new support around the $56.69 area.
* If you're looking for a slight discount you can look for an entry around the $56.69 area given it's acting as support
Caution:
* A daily close below $56.69 would negate the idea.
* Given the market conditions and your risk tolerance use your judgement as to where you should enter.
* A daily close below $56.69 could have the price around $53.73
Ipobase
APP breaking out of IPO base* High relative strength
* Breaking out of IPO base with slightly higher volume than average
* May consolidate and use $90 as support before moving higher.
PECO breaking out of IPO base!* General up trend
* Breaking out of a 2 month IPO base
* First broke the 30.40 level and turned it to support. Then broke the 31.13 level and has been testing it as support for the past 6 days.
* High relative strength; relative to the real estate market.
* Breaking out with higher than average volume
* Still close to the broken level.. Great time to buy
Unheard gross margins of 95% and a $800B TAM : $GDRXGoodRx is a free-to-use service that allows Americans to find the lowest-cost prescription drugs in their area. The company makes money by receiving a commission for every prescription order filled via its coupons, which are accepted by nearly all 70,000 pharmacies across the country.
-Most Downloaded medical app in US with 4.8/5 rating(700,000+ reviews)
-Partnership with Kroger
-Competing with TDOC with the launch of HeyDoctor
- Rising prices of pharmaceuticals and their mission is to lower the cost of healthcare
-95% Gross margin (What?!?!). 30% Operating margin.
- $75M Free cash flow.
- TAM $800 Mn
- NPS 86
- 4.6/5 Glassdoor
- Founder led
Concerns,
1. P/S of 37.1 and 201 PE. Average PE in healthcare is 24.
2. IPO hype(good for trades though)
3. 94% of top line revenue still coming in from prescription stream(concentration risk?) which grew 42% Q1.
4. Regulations
5. International expansion?
6. 4 holders own 60-65% of the company(Both good and bad)
TA,
1. Wedge breakout
2. Potential base of Cup.
3. Low volume on Pullback
Not a long term position yet. Swing trade.
Entry : break of 52
Stop loss : 49 (-7.8%)
Potential IPO base $LMNDPotential IPO base
"90 seconds to get insured. 3 minutes to get paid"
If you haven't already noticed, we are living in a world of immediate gratification. Insurance is just another sector that's ripe to be disrupted by better efficiency.
TA,
- Increasing volume and consolidating at previous highs $69.
FA,
- Disrupting the archaic industry of insurance
-High NPS score of 70. Industry average is 70.
- $5 Trillion TAM. Current market cap is $3.8Bn
- Huge barrier between insurance companies and customers. Making claims is a headache. Lemonade is bridging that gap through better customer service by leveraging the powers of AI. AI JIM and AI MAYA
- +167% revenue growth 2020
- Expansion beyond US. France is next by end of 2020.
- Only 3 types available still. Renters, home and pet insurance. More potential for other types
Concerns,
- Still not fully convinced of the business model
-Continued losses(side effect of disrupting)
- Price discovery phase still so will be super volatile.
Entry : Break of 69.2
Stop loss: 62.2
$FUTU - Potential long term leader just entered a buy point Chinese company operating in the financial services with great fundamentals.
